Xarelto Class Action Lawsuit
Xarelto is a hazardous blood-thinning drug that has no reversal. Plaintiffs believe Xarelto is unreasonably dangerous. Patients that are injured by the severe bleeding have filed over 18,000 lawsuits, but as MDL’s not part of any class action. There are also many individual lawsuits where people use their personal lawyers.
If you have found this page, there’s a good chance that you or a loved one has experienced some of the negative side effects of the drug Xarelto, and now you’re looking for options and information on how to proceed. If so, you’re in the right place.
Call 888-574-3737 to speak with a Lawyer.
Welcome to the Class Action Legal Center Xarelto information page. Here, you will find valuable insight and information on the medical conditions caused by the drug, your legal rights to recover damages or compensation, and the resources available to you in pursuit of that recovery. We hope that you will use this page to answer some of your general questions and to contact us with your more specific questions and concerns.
Legal Actions So Far
There are currently over 18,000 lawsuits pending before the court as of this writing, so clearly if you have experienced side effects of this drug, you aren’t alone. Obviously, the circumstances, details, and potential settlements in each case differ based on specifics. This is where the legal pros at Class Action Legal Center can help. We specialize in evaluating the individual circumstances of your case and connecting you with the best attorneys and firms in the nation to ensure you get the justice to which you are entitled. Our clients have already recovered hundreds of millions in damages and settlements in similar cases.
With this drug, what is alleged in many of the pending suits is that the drug makers and marketers were well aware of the high risk involved, and did not adequately disclose that risk to doctors and patients. If proven, this claim would make the drug maker legally liable for damages to anyone who suffered the ill effects of the drug. While this claim is hotly denied by the drugs’ manufacturers, it is easy to see how this could happen. Billions of dollars in annual sales are at stake, and Xarelto remains a popular and heavily prescribed medication. Time after time, consumers have seen their safety traded for higher Big Pharma profit margins. Many experienced attorneys believe that it has happened again here. Let the Class Action Law Center connect you with one of those skilled and successful attorneys.
What is Xarelto, and What Does it Do?
Xarelto is the name brand of the drug Rivaroxaban. It was developed in 2008 and approved by the FDA in 2011 by Bayer and is marketed in the US by Jassen Pharmaceutica. The drug is a blood thinner and anticoagulant and is used to treat and prevent averse blood clotting which can lead to stroke (deep vein thrombosis, pulmonary embolism, or the clotting effect of atrial fibrillation.) It is also commonly used after knee or hip surgeries, again, to prevent averse blood clotting.
Sounds pretty good, right?
Unfortunately, this drug has some quite severe side effects. People using it have suffered from gastrointestinal, cranial, and retinal hemorrhaging. Worse, and unlike other anticoagulants, there is no way to turn off the anticoagulant effect of the drug, as there is with other anticoagulants, in an emergency. Doctors have seen patients bleed to death and had no way to stop it, due to this critical and potentially deadly shortcoming.
What Happens Now?
Now is the time for you to take action. The statute of limitation for claims of this kind can quickly run out while you try to decide what to do. If you, or someone you care about, has suffered the destructive and terrifying effects of this drug, please reach out to the trusted professionals at Class Action Law Center today. Our team of trusted experts will evaluate the details of your case and experience, and give you a realistic appraisal of chances and expectations for damages and compensation.
What’s more, there is no fee, and no risk, in doing so. We work with only the top attorneys and firms, and they only receive compensation if they recover damages on your behalf. Class Action Law Center can get you started right now on the road to recovery. The process begins today. Fill out the form on this page to provide us with the details we need to connect you with the attorney most suited to your specific case. It’s quick, easy, and absolutely free.
Big Pharma has an army of Xarelto Lawsuit lawyers in their service. Shouldn’t you have one to match? At Class Action Legal Center, we have our own force of experienced, skilled, and trustworthy attorneys ready to fight for you. Don’t wait another day to get started!
Bellwether Trials in the Xarelto MDL is Set to Begin This Spring
A judge, Eldon E Fallon of the U.S. District Court in Louisiana has moved the date for the long-awaited bellwether trials ahead to April 2017. Initially, the trial date had been set to begin in February but due to a conflict of scheduled events, the trial start date had to be pushed to April.
The Xarelto bellwether trials will serve to help the attorneys and judges involved in the now massive number of case to determine how the following cases may go. Over the past few years, claims against Johnson & Johnson and Bayer, the massive healthcare companies and the makers have begun to stack up. Now it is estimated that the number of lawsuits against the healthcare juggernauts has grown to around 10,000.
Risk of Bleeding
Originally approved for its introduction into the market by the FDA in 2012 it fast became one of the top-selling drugs on the market. Soon, however, it became apparent the drug was problematic as thousands of reports started surfacing regarding the drug’s deadly side effects. After less than a year, 2,000 reports were made including 151 deaths. In 2014, the FDA released a warning that Xarelto may cause uncontrollable hemorrhaging. The warning also stated that there was no known antidote to stop the bleeding once it started.
The Bellwether Trials and the MDL
In December of 2014, MDL 2592 was established by Lawyers in the Eastern District of Louisiana by the U.S. Judicial Panel on Multidistrict Litigation. On January 29, 2015, the first Xarelto MDL pretrial conference was held by Judge Fallon. After much preparation, the first case is set for trial in April 2017.
The Eastern District of Louisiana will host the first two Bellwether trials which are set for April 24, 2017, which is the Joseph Boudreaux case, and the Joseph Orr case which is set for May 30, 2017. The next two Bellwether trials will be conducted in the Southern District of Mississippi in June 2017 and in the North District of Texas in July 2017.
The Boudreaux case was filed in December 2014. The plaintiff, in this case, claims that he was prescribed for his atrial fibrillation in order to reduce the risk of stroke. However, within a month of taking it, Mr. Boudreaux suffered from a severe and life-threatening gastrointestinal bleed. The plaintiff was hospitalized and received several blood transfusions.
In the Orr case, the plaintiff and her Lawyers allege that his wife, Sharon began taking Rivaroxaban in May 2015 for atrial fibrillation. It is alleged that within one month of her using Rivaroxaban she developed a brain hemorrhage and died after being hospitalized and suffering for 10 days from the bleed.
Plaintiffs in these cases are alleging that the company failed to provide patients with an adequate warning as to the severity of side effects that can accompany taking the drug. They are also claiming that the company fraudulently claimed the drug was safer than other drugs that are used for the same conditions through false advertising. It is alleged that the company also did not make consumers aware of the fact that there is not an antidote to treat the most severe and deadly side effect of Xarelto which is internal bleeding. In addition, it is alleged physicians were encouraged to prescribe the medication without proper knowledge of the severity of the risks of life-threatening side effects.
Xarelto is prescribed to those who have an increased risk of blood clots primarily in patients who suffer from atrial fibrillation. The drug acts as a blood thinner to prevent or treat types of blood clots called deep vein thrombosis or pulmonary embolus. It is an anticoagulant that works by blocking certain proteins in the blood that contribute to clotting.
If you or someone you know has suffered life-threatening side effects or death you may be entitled to receive compensation for your suffering. If you have suffered from any side effects or health complications from the use of Xarelto, we can help you.
There are about 2,000 class action cases involved in the Xarelto Settlements, but it is expected that several thousand additional cases will be filed over the next year or two. The number of lawsuits is expected to grow however due to the fact that as more and more people take the drug, there is an increase in the amount of people with adverse side effects.[/vc_column_text]
The Bellwether MDL Case Update
Lawsuit #1: Betty Samson
Canadian resident Betty Samson was taking the drug in September of 2012 and fell into cardiac arrest shortly after. She alleges that doctors were “unable to quickly stabilize the internal bleeding allegedly linked to her use.” Samson also states that, “the health care professionals treating her had extreme difficulty in stopping her bleeding.”
According to her complaint, Health Canada has received at least 1,100 documented cases of adverse side effects. In her Xarelto class action lawsuit, She includes in her complaint reports from Germany that linked to 130 deaths between 2012 and 2013.
Lawsuit #2: Virginia Stunteneck
Virginia Stunteneck, a resident of Kentucky, filed a similar blood clot lawsuit against medical giant Bayer stating that she was hospitalized after she took Xarelto and was affected by severe gastrointestinal bleeding in 2013.
According to Stuteneck, the drug manufacturers knew their medicine came with serious side effects but chose to manufacture it anyway. Stuteneck’s lawyers in the Bayer lawsuit state that the drug conglomerate remained silent about the possibly deadly side effects despite the mounting evidence against the drug.
Lawsuit #3: Margaret Garvy
In another recent lawsuit filed by Margaret Garvy, she alleges the side effects caused her to suffer bleeding complications. In court, Garvy states she only took the drug for less than two weeks during May of 2014 and was soon diagnosed with hemorrhagic pericardial effusion, pericardial tamponade and pleural effusion.
These conditions indicate bleeding around the heart and lungs and were reportedly linked to her Xarelto use.
Xarelto Class Action Lawsuits
Before taking Xarelto consult with a medical professional. The litigation mentioned on this page are not reflective of every case, so prior to taking any need medications you should always seek the advice of your doctor or a specialist. For more information about Xarelto Class Action Lawsuits please continue to our
Xarelto is an anticoagulant manufactured by Bayer and Johnson & Johnson prescribed to those who have an increased risk of blood clots. The drug is primarily used with patients who suffer from atrial fibrillation but it is also commonly used in patients who undergo knee or hip replacement. The drug acts as a blood thinner to prevent or treat types of blood clots called deep vein thrombosis or pulmonary embolus. It works by blocking certain proteins in the blood that contribute to clotting.
Within months of the drug hitting the market in 2011, severe and deadly side effects began to surface. This spurred a high number of injury and wrongful death lawsuits against the makers of Rivaroxaban. Plaintiffs in these cases are alleging that the company failed to provide patients with an adequate warning as to the severity of side effects that can accompany taking the drug. They are also claiming that the company fraudulently claimed the drug was safer than other drugs that are used for the same conditions through false advertising. It is alleged that the company also did not make consumers aware of the fact that there is not an antidote to treat the most severe and deadly side effect of Xarelto which is internal bleeding. In addition, it is alleged physicians were encouraged to prescribe the medication without proper knowledge of the severity of the risks of life-threatening side effects.
William Packard was prescribed Xarelto to treat his atrial fibrillation (AFib). His physician prescribed the medication as an alternative to Warfarin which is a long-standing anticoagulant. This drug was said to be less obtrusive for the patient because it did not require the patient to go through blood monitoring or dose adjustments. However, six months into Mr. Packard’s use, he began to suffer from severe headaches and bouts of confusion. Mr. Packard was diagnosed with a subdural hemorrhage. A subdural hemorrhage is a life-threatening condition in which blood leaks around and outside of the brain. Mr. Packard died five days after being admitted to the hospital for his subdural hemorrhage.
Thomas Dunkley also suffered from AFib. He was also prescribed Xarelto for his issue by his physician. Within mere days of starting the drug, he began to experience severe headaches. Two weeks after starting, Mr. Dunkley died from a subdural hemorrhage.
These stories have become commonplace among plaintiffs who are seeking justice against Bayer and Johnson & Johnson, the makers. Xarelto had been advertised as a safer and less obtrusive alternative to its competitors such as Warfarin. However, it quickly became apparent that Xarelto’s issues were extremely deadly. Unfortunately, the makers appear to have been negligent in the making and marketing of the drug and failed to make the public aware its dangers or disengage their high-profile ad campaign.
- Bayer and Johnson & Johnson intentionally withheld the fact that Xarelto increased the risk for deadly hemorrhaging.
- The makers intentionally withheld the fact that there is no active antidote for the bleeding issues Xarelto can cause.
- The makers misled patients and physicians through false claims in a high-profile and aggressive ad campaign.
- The makers funded studies that have been shown to have produced skewed results that led many to believe Xarelto was safe.
- The makers intentionally concealed evidence of the dangers of Xarelto from the public and the FDA.
- The makers were negligent in the manufacturing of Xarelto.
The first lawsuit which is an MDL (Multidistrict Litigation) and will serve as the bellwether trial is now underway in Louisiana. First scheduled for February 2017, the trial was delayed until March 2017 due to scheduling conflicts. At this time it is estimated to be around 10,000 lawsuits being filed against Bayer and Johnson & Johnson’s anticoagulant medication, Xarelto. The bellwether trial in Louisiana will serve to set the tone for future verdicts or settlements in other lawsuits that will follow. Currently, trials are being scheduled around the country for litigation against the makers of Xarelto. If you or a loved one have suffered from life-threatening or fatal side effects of Xarelto, we can help you get the justice and compensation you deserve.